Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study
Francesco Ferrara, Carolina Mancaniello, Alessia Varriale, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 12, pp. 1065-1074
Open Access | Times Cited: 18

Showing 18 citing articles:

Recovery of suspended reimbursements of high-cost drugs subjected to monitoring registries and negotiated agreements (MEAs): a tool for governance and clinical appropriateness in the Italian reality
Maurizio Capuozzo, Venere Celotto, Andrea Zovi, et al.
The European Journal of Health Economics (2023) Vol. 25, Iss. 1, pp. 1-5
Open Access | Times Cited: 18
Trend analysis of proton pump inhibitor consumption and expenditure: The real-world evidence
Francesco Ferrara, Maurizio Capuozzo, Venere Celotto, et al.
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 3, pp. 645-651
Closed Access | Times Cited: 7
Impact of the COVID ‐19 pandemic on clinical autonomic practice in Europe: a survey of the European Academy of Neurology and the European Federation of Autonomic Societies
Alessandra Fanciulli, Fabian Leys, Magdalena Krbot Skorić, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 6, pp. 1712-1726
Open Access | Times Cited: 16
SARS-CoV-2 caused a surge in antibiotic consumption causing a silent pandemic inside the pandemic. A retrospective analysis of Italian data in the first half of 2022
Francesco Ferrara, Andrea Zovi, Eduardo Nava, et al.
Annales Pharmaceutiques Françaises (2023) Vol. 81, Iss. 4, pp. 627-635
Open Access | Times Cited: 15
New drugs for type 2 diabetes mellitus: The challenge of the health care sustainability combined with a better patient care access
Francesco Ferrara, Andrea Zovi, Roberto Langella, et al.
International Journal of Healthcare Management (2023) Vol. 17, Iss. 3, pp. 556-561
Closed Access | Times Cited: 12
Vaccine development against tuberculosis before and after Covid-19
Stefan H. E. Kaufmann
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Parkinson’s Disease: New Therapeutic Developments from L-DOPA to Digital Therapies
Francesco Ferrara
SN Comprehensive Clinical Medicine (2025) Vol. 7, Iss. 1
Closed Access
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review
Katharine Valéria Saraiva Hodel, Bianca Sampaio Dotto Fiuza, Rodrigo Souza Conceição, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 807-807
Open Access | Times Cited: 3
Food Supplements Marketed Worldwide: A Comparative Analysis Between the European and the U.S. Regulatory Frameworks
Andrea Zovi, Antonio Vitiello, Michela Sabbatucci, et al.
Journal of Dietary Supplements (2024), pp. 1-16
Closed Access | Times Cited: 3
Sex affects immune response capacity against COVID‐19 infection
Andrea Zovi, Francesco Ferrara, Roberto Langella, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 4
Closed Access | Times Cited: 8
The Italian experience with the use of monitoring registers attached to negotiated agreements (MEAs) of the Italian Medicines Agency is a tool for governance and clinical appropriateness
Maurizio Capuozzo, Venere Celotto, Alessandro Ottaiano, et al.
Journal of Cancer Policy (2023) Vol. 38, pp. 100450-100450
Closed Access | Times Cited: 2
Covid-19 psychological distress: Analysis of antipsychotic drugs’ use in an Italian population sample
Francesco Ferrara, Maurizio Capuozzo, Ugo Trama, et al.
Annales Pharmaceutiques Françaises (2024) Vol. 82, Iss. 5, pp. 840-847
Closed Access
Sustainability and evolution of health care regarding treatments concerning type 2 diabetes mellitus
Francesco Ferrara, Andrea Zovi, R. Langella, et al.
Ethics Medicine and Public Health (2023) Vol. 28, pp. 100890-100890
Closed Access | Times Cited: 1
COVID-19 Pandemic: Therapeutic Strategies and Vaccines
Mariarosaria Boccellino
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 556-556
Open Access | Times Cited: 1
The diabetic patient between sustainability and effectiveness of new treatments
Francesco Ferrara, Andrea Zovi, Roberto Langella, et al.
Journal of Diabetes & Metabolic Disorders (2023) Vol. 22, Iss. 2, pp. 1635-1643
Open Access
Reply to “The nature and severity of SARS-CoV-2 vaccines side effects are highly dependent on study design” and “Self-reported side effects following COVID-19 vaccination in athletes: Correspondence”
Klara Komici, Sofia Verderosa, Fabio D’Amico, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access
Adverse Events Following mRNA COVID-19 Vaccine in 2021 and 2022: A Retrospective Analysis in Costa Rica and Italy
Bruno Serrano‐Arias, Francesco Ferrara, Esteban Zavaleta‐Monestel, et al.
Cureus (2023)
Open Access
The Covid-19 and TB Syndemic: Differences and Similarities
Stefan H. E. Kaufmann, Alan Sher, Alex Sigal, et al.
Frontiers research topics (2023)
Open Access
Page 1

Scroll to top